Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Elagolix

An oral non-peptide GnRH receptor antagonist that lowers oestrogen production. It was approved in the United States in 2018 for moderate to severe endometriosis pain. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?It blocks the receptor for GnRH, a peptide hormone made in the brain: for their discoveries on these hormones Andrew Schally and Roger Guillemin received the Nobel Prize in Medicine in 1977.

Elagolix SodiumGo to the active ingredient →

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.